Lataa...
CDK4/6 and MAPK—Crosstalk as Opportunity for Cancer Treatment
Despite the development of targeted therapies and novel inhibitors, cancer remains an undefeated disease. Resistance mechanisms arise quickly and alternative treatment options are urgently required, which may be partially met by drug combinations. Protein kinases as signaling switchboards are freque...
Tallennettuna:
| Julkaisussa: | Pharmaceuticals (Basel) |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7760252/ https://ncbi.nlm.nih.gov/pubmed/33255177 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph13120418 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|